VBWG
Data alert

Preventing stroke with ACE inhibition

Each year, approximately 750,000 Americans suffer a first or recurrent stroke. Older persons are at higher risk than the general population, with a doubling in stroke risk for every decade after the age of 55. Approximately 72% of strokes occur in people over 65 years old. This issue of Data Alert discusses the clinical and economic implications of stroke and reviews new data on primary and secondary prevention strategies.





DA8.ppt

Download DA8.ppt (9 slides - 1.3MB)

Slide 1 Slide 2 Slide 3 Slide 4 Slide 5 Slide 6 Slide 7 Slide 8 Slide 9
Data_Alert.pdf (0.3MB)Data_Alert.pdf (0.3MB)


ACEinhibitionStroke

Related at vwbg.org

Vascular Biology in Clinical Practice © Vol. 7, No. 1

ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection

This monograph, ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection , which is being offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 6, No. 3

A HOPE FOR PEACE? Update on the role of ACE inhibition in CAD patients

This monograph, A HOPE for PEACE? Update on the role of ACE inhibition in CAD patients , is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Decrease in PAI-1 antigen is greater with ACE inhibition

Plasminogen activator inhibitor-1 (PAI-1) is a known risk factor for cardiovascular (CV) disease and myocardial infarction (MI).
More related